These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24751702)

  • 1. Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma.
    Fard-Esfahani A; Emami-Ardekani A; Fallahi B; Fard-Esfahani P; Beiki D; Hassanzadeh-Rad A; Eftekhari M
    Nucl Med Commun; 2014 Aug; 35(8):808-17. PubMed ID: 24751702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and late adverse effects of radioiodine for pediatric differentiated thyroid cancer.
    Albano D; Bertagna F; Panarotto MB; Giubbini R
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28436606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of different doses of radioactive iodine for remnant ablation on successful ablation and on long-term recurrences in patients with differentiated thyroid carcinoma.
    Kim EY; Kim TY; Kim WG; Yim JH; Han JM; Ryu JS; Hong SJ; Yoon JH; Gong G; Kim WB; Shong YK
    Nucl Med Commun; 2011 Oct; 32(10):954-9. PubMed ID: 21849927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B; Handkiewicz-Junak D; Wloch J
    Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary gland dysfunction and nasolacrimal duct obstruction: stenotic changes following I-131 therapy.
    Savage MW; Sobel RK; Hoffman HT; Carter KD; Finkelstein MW; Shriver EM
    Ophthalmic Plast Reconstr Surg; 2015; 31(3):e50-2. PubMed ID: 24836449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
    Nakada K; Ishibashi T; Takei T; Hirata K; Shinohara K; Katoh S; Zhao S; Tamaki N; Noguchi Y; Noguchi S
    J Nucl Med; 2005 Feb; 46(2):261-6. PubMed ID: 15695785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Radioactive Iodine Ablation Therapy on Voice Quality.
    Aydoğdu İ; Atar Y; Saltürk Z; Sarı H; Ataç E; Aydoğdu Z; İnan M; Mersinlioğlu G; Uyar Y
    J Voice; 2017 Jan; 31(1):94-96. PubMed ID: 27377232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation.
    Grewal RK; Larson SM; Pentlow CE; Pentlow KS; Gonen M; Qualey R; Natbony L; Tuttle RM
    J Nucl Med; 2009 Oct; 50(10):1605-10. PubMed ID: 19759114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma.
    Alexander C; Bader JB; Schaefer A; Finke C; Kirsch CM
    J Nucl Med; 1998 Sep; 39(9):1551-4. PubMed ID: 9744341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid lobe ablation with iodine- ¹³¹I in patients with differentiated thyroid carcinoma: a randomized comparison between 1.1 and 3.7 GBq activities.
    Giovanella L; Piccardo A; Paone G; Foppiani L; Treglia G; Ceriani L
    Nucl Med Commun; 2013 Aug; 34(8):767-70. PubMed ID: 23652210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent disease in juvenile differentiated thyroid carcinoma: prognostic factors, treatments, and outcomes.
    Mihailovic J; Nikoletic K; Srbovan D
    J Nucl Med; 2014 May; 55(5):710-7. PubMed ID: 24722527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Side effects of "rational dose" iodine-131 therapy for metastatic well-differentiated thyroid carcinoma.
    Van Nostrand D; Neutze J; Atkins F
    J Nucl Med; 1986 Oct; 27(10):1519-27. PubMed ID: 3760975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiated thyroid cancer: lobectomy and radioiodine, a treatment suitable for all cases?
    Allan E; Owens SE; Waller ML
    Nucl Med Commun; 1999 Nov; 20(11):983-9. PubMed ID: 10572907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radioiodine therapy and radioiodine after-care in differentiated thyroid gland carcinomas].
    Börner AR; Müller-Gärtner HW
    Zentralbl Chir; 1997; 122(4):274-85. PubMed ID: 9221638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of radioactive iodine for adjuvant therapy and treatment of metastases.
    Jonklaas J
    J Natl Compr Canc Netw; 2007 Jul; 5(6):631-40. PubMed ID: 17623614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialoadenitis secondary to ¹³¹I therapy for well-differentiated thyroid cancer.
    Van Nostrand D
    Oral Dis; 2011 Mar; 17(2):154-61. PubMed ID: 21029259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up of differentiated thyroid carcinoma.
    Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
    Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radioiodine therapy in differentiated thyroid gland carcinoma].
    Schicha H; Dietlein M
    Zentralbl Chir; 1997; 122(4):266-73. PubMed ID: 9221637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.